ClinVar Miner

Submissions for variant NM_000161.3(GCH1):c.323G>A (p.Gly108Asp)

dbSNP: rs104894435
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000634833 SCV000756177 pathogenic Dystonia 5; GTP cyclohydrolase I deficiency 2023-12-13 criteria provided, single submitter clinical testing This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 108 of the GCH1 protein (p.Gly108Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with dystonia (PMID: 9667588, 15753436; Invitae). ClinVar contains an entry for this variant (Variation ID: 9282). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GCH1 protein function with a positive predictive value of 80%. This variant disrupts the p.Gly108 amino acid residue in GCH1. Other variant(s) that disrupt this residue have been observed in individuals with GCH1-related conditions (PMID: 16917893, 17898029), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Athena Diagnostics Inc RCV001659690 SCV001880603 pathogenic not provided 2021-05-07 criteria provided, single submitter clinical testing This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant associates with disease in multiple families. The GCH1 gene is reported to exhibit gender-related incomplete penetrance of disease. Consistent with this variability, this variant has been reported in individuals with clinical presentations ranging from severe DRD, to adult-onset parkinsonism, to asymptomatic. Computational tools predict that this variant is damaging.
OMIM RCV002508113 SCV000030085 pathogenic Dystonia, dopa-responsive, with or without hyperphenylalaninemia, autosomal recessive 1998-07-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.